Neuro-2a Transfection Reagent (Neuroblastoma Cells, CCL131)

Altogen Biosystems is a recognized developer and laboratory for genetic research. Custom research offers and additional experiments include xenografts, toxicology assays, 28-day generation of stably-transfected cells, RNAi testing and more. Dedicated to assisting pharmaceutical companies with cutting-edge and specialized services, Altogen Biosystems endeavors to optimize modern laboratory discoveries. Visit Altogen’s catalog for brain cancer xenograft models and other tools for preclinical research and drug development.

The Neuro-2a cell line was derived from the brain tissue of an albino mouse with a neuroblastoma. The cell line has been used extensively to study the formation of neuroblastomas and the resulting metastasis into bone tissues in children; the cell line is susceptible to viral infection and is consequentially an important model for investigating tumorigenesis in children after birth. With viruses such as poliovirus 1, vesicular stomatitis, and herpes simplex having the capability to be passed on to children during pregnancy, research with non-intrusive transfection reagents accompanying gene therapies can help elucidate cures to virus-caused cancers in children.